{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D002470",
      "entity_text" : "cell viability",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04932",
      "entity_text" : "trastuzumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The almost insignificant loss of cell viability induced by trastuzumab in both parental and negative control shRNA transduced cells (i.e., 1% reduction at 1 mug/mL trastuzumab and 8% reduction at 100 mug/mL trastuzumab) were significantly augmented in ATG8 / LC3 shRNA / JIMT1 cells (i.e., from 19% reduction at 1 mug/mL trastuzumab to 30% reduction at 100 mug/mL trastuzumab).",
  "reading_complete" : "2020-08-04T13:45:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:43:10Z",
  "trigger" : "induced",
  "evidence" : [ "cell viability induced by trastuzumab" ],
  "pmc_id" : "3749547",
  "score" : 0
}